Chiroscience Chirocaine
Executive Summary
Zeneca will market the long-acting local anesthetic levobupivacaine in all markets excluding Japan in exchange for a $25 mil. buy-in of Chiroscience stock. Cambridge, England-based Chiroscience plans to submit an NDA for Chirocaine in April